ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Review Group Urges Increased Funding For NCI AIDS Drug Discovery Program

December 3, 1999

NCI Develops Plan For Specialized Centers, But Funding $67.5M Program Depends On New $$

July 5, 1991

NCAB Subcommittee Tells Califano To Keep Hands Off Board Appointments

May 18, 1979

Nursing Center Moves Onto Campus

May 9, 1986

NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas

January 23, 1987

Foundation Issues Call For Tobacco Policy Research Proposals

November 27, 1992